Skip to main content

Table 2 Distribution of people in each age group, with low, medium or high risk for pneumococcal diseases or their complications[21]

From: Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia

Age groups Risk level
  Low Medium High
50 – 64 years 52.2% 36.6% 11.2%
65 – 74 years 41.7% 38.5% 19.8%
75 – 84 years 37.4% 36.9% 25.7%
85 – 99 years 36.6% 34.3% 29.1%